Our findings illustrate how hydrodynamic tail vein injection combining two “open” predisposition genetic alterations, the Alb-R26Met mice and Myc, can generate clinically relevant inside-out models of HCC subgroups. The gene discussed is ALB; the disease is hepatocellular carcinoma.